Agios Pharmaceuticals Inc. develops and delivers transformative therapies for patients with rare diseases, including hemolytic anemias such as pyruvate kinase (PK) deficiency and thalassemia. The company serves patients in the U.S., Europe, and other regions through its commercial and clinical-stage products.
Some research tools need a free Smallfolk account or a Smallfolk Pro plan.